Lv1
78 积分 2024-08-12 加入
Association of cardiovascular disease risk factors with late cardiotoxicity and survival in HER2-positive breast cancer survivors
1个月前
已关闭
Reciprocal Mechanisms Linking Cancer and Cardiovascular Disease: Emerging Paradigms in Onco-Cardiology
2个月前
已完结
Long-term cardiotoxicity outcomes of trastuzumab and cardiac safety of novel HER2-targeted therapies
2个月前
已完结
Efficacy and safety of insulin sensitisers for treating type 2 diabetes: a network meta-analysis
2个月前
已完结
Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis
4个月前
已完结
Switching to a Fixed-dose Combined Pertuzumab and Trastuzumab With Recombinant Human Hyaluronidase Subcutaneous Injection to Treat Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Real-world UK Clinical Practice
4个月前
已完结
Efficacy and Safety of Subcutaneous Pertuzumab–Trastuzumab (Phesgo) in Neoadjuvant Treatment of HER2-positive Breast Cancer: Real-world Data from Japan
4个月前
已完结
Cost-Effectiveness of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in HER2-Positive Early Breast Cancer in China: A Post-Hoc Analysis of the FeDeriCa Trial
5个月前
已关闭
Real-world effectiveness and safety of galcanezumab for the treatment of migraine: A systematic review and meta-analysis
5个月前
已完结
Cost-Effectiveness of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in HER2-Positive Early Breast Cancer in China: A Post-Hoc Analysis of the FeDeriCa Trial
5个月前
已关闭
皖公网安备34019202002308
